American Journal of Neuroradiology, Vol 19, Issue 9 1695-1703, Copyright © 1998 by American Society of Neuroradiology
ARTICLES |
Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm
HG Krouwer, TA Kim, SD Rand, RW Prost, VM Haughton, KC Ho, SS Jaradeh, GA Meyer, KA Blindauer, JF Cusick, GL Morris and PR Walsh
Department of Neurology, Medical College of Wisconsin, Milwaukee 53226, USA.
BACKGROUND AND PURPOSE: MR spectroscopy is used to characterize biochemical components of normal and abnormal brain tissue. We sought to evaluate common histologic findings in a diverse group of nonneoplastic diseases in patients with in vivo MR spectroscopic profiles suggestive of a CNS neoplasm. METHODS: During a 2-year period, 241 patients with suspected neoplastic CNS lesions detected on MR images were studied with MR spectroscopy. Of these, five patients with a nonneoplastic diagnosis were identified retrospectively; a sixth patient without tissue diagnosis was added. MR spectroscopic findings consistent with a neoplasm included elevated choline and decreased N- acetylaspartate and creatine, with or without detectable mobile lipid and lactate peaks. RESULTS: The histologic specimens in all five patients for whom tissue diagnoses were available showed significant WBC infiltrates, with both interstitial and perivascular accumulations of lymphocytes, macrophages, histiocytes, and (in one case) plasma cells. Reactive astrogliosis was also prominent in most tissue samples. This cellular immune response was an integral component of the underlying disorder in these patients, including fulminant demyelination in two patients, human herpesvirus 6 encephalitis in one patient, organizing hematoma from a small arteriovenous malformation in one patient, and inflammatory pseudotumor in one patient. Although no histologic data were available in the sixth patient, neoplasm was considered unlikely on the basis of ongoing clinical and neuroradiologic improvement without specific therapy. CONCLUSION: Nonneoplastic disease processes in the CNS may elicit a reactive proliferation of cellular elements of the immune system and of glial tissue that is associated with MR spectroscopic profiles indistinguishable from CNS neoplasms with current in vivo MR spectroscopic techniques. Such false-positive findings substantiate the need for histologic examination of tissue as the standard of reference for the diagnosis of intracranial mass lesions.
This article has been cited by other articles:
 |
|
 |
|
  P. L. Sah, R. Sharma, H. Kandpal, A. Seith, S. Rastogi, S. Bandhu, and N. R. Jagannathan In Vivo Proton Spectroscopy of Giant Cell Tumor of the Bone Am. J. Roentgenol., February 1, 2008; 190(2): W133 - W139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cianfoni, S. Niku, and S.G. Imbesi Metabolite Findings in Tumefactive Demyelinating Lesions Utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-K. Wang, C.-W. Li, T.-J. Hsieh, S.-H. Chien, G.-C. Liu, and K.-B. Tsai Characterization of Bone and Soft-Tissue Tumors with in Vivo 1H MR Spectroscopy: Initial Results Radiology, August 1, 2004; 232(2): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Samann, J. Schlegel, G. Muller, F. Prantl, C. Emminger, and D. P. Auer Serial Proton MR Spectroscopy and Diffusion Imaging Findings in HIV-Related Herpes Simplex Encephalitis AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 2015 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Saraf-Lavi, B. C. Bowen, P. M. Pattany, E. M.L. Sklar, J. B. Murdoch, and C. K. Petito Proton MR Spectroscopy of Gliomatosis Cerebri: Case Report of Elevated Myoinositol with Normal Choline Levels AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 946 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bulakbasi, M. Kocaoglu, F. Ors, C. Tayfun, and T. Ucoz Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors AJNR Am. J. Neuroradiol., February 1, 2003; 24(2): 225 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Gupta, D. K. Vatsal, N. Husain, S. Chawla, K. N. Prasad, R. Roy, R. Kumar, D. Jha, and M. Husain Differentiation of Tuberculous from Pyogenic Brain Abscesses with In Vivo Proton MR Spectroscopy and Magnetization Transfer MR Imaging AJNR Am. J. Neuroradiol., September 1, 2001; 22(8): 1503 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-P. Schlemmer, P. Bachert, K. K. Herfarth, I. Zuna, J. Debus, and G. van Kaick Proton MR Spectroscopic Evaluation of Suspicious Brain Lesions After Stereotactic Radiotherapy AJNR Am. J. Neuroradiol., August 1, 2001; 22(7): 1316 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Maheshwari, S. K. Mukherji, B. Neelon, S. Schiro, G. M. Fatterpekar, J. A. Stone, and M. Castillo The Choline/Creatine Ratio in Five Benign Neoplasms: Comparison with Squamous Cell Carcinoma by Use of in Vitro MR Spectroscopy AJNR Am. J. Neuroradiol., November 1, 2000; 21(10): 1930 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Butzen, R. Prost, V. Chetty, K. Donahue, R. Neppl, W. Bowen, S.-J. Li, V. Haughton, L. Mark, T. Kim, et al. Discrimination between Neoplastic and Nonneoplastic Brain Lesions by Use of Proton MR Spectroscopy: The Limits of Accuracy with a Logistic Regression Model AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1213 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bendszus, M. Warmuth-Metz, R. Klein, R. Burger, C. Schichor, J. C. Tonn, and L. Solymosi MR Spectroscopy in Gliomatosis Cerebri AJNR Am. J. Neuroradiol., February 1, 2000; 21(2): 375 - 380. [Abstract] [Full Text]
|
|